Different clinical specialists in the management of inflammatory diseases discuss the role of adalimumab biosimilars in the treatment of their patients.
EP. 1: The Need for Biosimilars in Inflammatory Diseases and Regulatory Requirements for Approval
March 29th 2024Drs Lio, Botsoglou, and Axelrad discuss the need for biosimilars in inflammatory diseases, and clinical pharmacist Dr Humphreys reviews the regulatory requirements for biosimilars to receive FDA approval.
EP. 4: The Safety and Efficacy of Adalimumab Biosimilars in Inflammatory Diseases
April 5th 2024Specialists in rheumatology, dermatology and gastrointestinal disease discuss clinical trials that have shown safety and efficacy of adalimumab biosimilars in inflammatory diseases.
EP. 5: Impact of the Launch of Adalimumab Biosimilars in Different Clinical and Pharmacy Settings
April 12th 2024Experts talk about the impact of the launch of adalimumab biosimilar on their clinical practices and pharmacy.
EP. 6: The Role of Pharmacy Benefit Managers and Payers in Accessing Adalimumab Biosimilars
April 12th 2024A clinical pharmacist discusses the role of pharmacy benefit managers and payers in accessibility of adalimumab biosimilars.
EP. 7: Strategies to Increase Adalimumab Biosimilar Uptake in Clinical Practice
April 19th 2024A clinical pharmacist and specialists in rheumatology, dermatology, and gastrointestinal disease share strategies in how to increase the uptake of adalimumab biosimilar among providers.
EP. 8: Selecting Between Adalimumab Biosimilars for Your Patients
April 19th 2024Providers in rheumatology, dermatology and gastrointestinal disease talk about how they are selecting between the various adalimumab biosimilars available for their patients.
EP. 9: Switching From Adalimumab to a Biosimilar
April 29th 2024Specialists in rheumatology, dermatology and gastrointestinal disease discuss the evidence on efficacy and safety on switching patient to an adalimumab biosimilar.
EP. 10: Clinical Experience With Initiating Adalimumab Biosimilars
April 29th 2024Specialists in rheumatology, dermatology and gastrointestinal disease share their clinical experience on initiating or switching their patients on adalimumab biosimilars.
EP. 11: The Role of Health Care Providers on Encouraging Adalimumab Biosimilar Use
May 3rd 2024Healthcare providers in inflammatory diseases talk about the role they have on encouraging adalimumab biosimilar use in clinical practice.
2 Commerce Drive
Cranbury, NJ 08512